• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Axio Research expands services into China

Axio Research expands services into China

November 7, 2011
CenterWatch Staff

Axio Research, a North American independent data coordinating center, has expanded its services into Shanghai, China.

“Offering independent safety and/or efficacy clinical events analysis for our clients, when and where they need the work performed, is part of what Axio offers to our clients,” said Lee Hooks, CEO.  “As a leader in Data Monitoring Committee Services as well as Clinical Event Committees, we have seen increased demand for our services and delivered an improved research value for our clients as they make the most informed decisions possible for placement of their research and development dollars.”

Kent Koprowicz, head of biostatistics, said “China-based organizational meetings are relatively new to most of our clients and the industry.  Our expert and diverse Chinese speaking staff enable us to deliver effective communications and planning supporting organizational meetings, safety and efficacy analysis reporting, and software programming for China-based committees.”

Axio Research’s lead biostatistician and project director will serve in lead roles with the client’s global teams. They will jointly schedule turnaround times for interim analysis and final reports and oversee the project charter.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing